These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17219448)

  • 1. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma.
    Dehn D; Torkko KC; Shroyer KR
    Cancer; 2007 Feb; 111(1):1-14. PubMed ID: 17219448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection.
    Pientong C; Ekalaksananan T; Kongyingyoes B; Kritpetcharat O; Swadpanich U; Pengsa P; Yuenyao P
    Diagn Cytopathol; 2004 Oct; 31(4):235-42. PubMed ID: 15452898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.
    Reuschenbach M; Clad A; von Knebel Doeberitz C; Wentzensen N; Rahmsdorf J; Schaffrath F; Griesser H; Freudenberg N; von Knebel Doeberitz M
    Gynecol Oncol; 2010 Oct; 119(1):98-105. PubMed ID: 20619445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening.
    Ekalaksananan T; Pientong C; Sriamporn S; Kongyingyoes B; Pengsa P; Kleebkaow P; Kritpetcharat O; Parkin DM
    Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.
    Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P
    Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia.
    Wentzensen N; Bergeron C; Cas F; Vinokurova S; von Knebel Doeberitz M
    Cancer; 2007 Feb; 111(1):58-66. PubMed ID: 17186505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus detection: verification with cervical cytology.
    Matthews-Greer J; Rivette D; Reyes R; Vanderloos CF; Turbat-Herrera EA
    Clin Lab Sci; 2004; 17(1):8-11. PubMed ID: 15011974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
    Lie AK; Kristensen G
    Expert Rev Mol Diagn; 2008 Jul; 8(4):405-15. PubMed ID: 18598223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus testing for primary cervical cancer screening.
    Grce M; Davies P
    Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods.
    Layfield LJ; Qureshi MN
    Diagn Cytopathol; 2005 Aug; 33(2):138-43. PubMed ID: 16007672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
    Arbyn M; Sasieni P; Meijer CJ; Clavel C; Koliopoulos G; Dillner J
    Vaccine; 2006 Aug; 24 Suppl 3():S3/78-89. PubMed ID: 16950021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytologic diagnosis of atypical squamous cells of undetermined significance in perimenopausal and postmenopausal women: lessons learned from human Papillomavirus DNA testing.
    Johnston EI; Logani S
    Cancer; 2007 Jun; 111(3):160-5. PubMed ID: 17506090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of human papillomavirus test in triage of patients with atypical squamous cell of undetermined significance].
    Zhao J; Zhou JN; Yang YJ; Liao QP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):299-301. PubMed ID: 19105350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cell protein p16INK4a hyperexpression in epithelial malignancies induced by human papillomaviruses].
    Volgareva GM; Zavalishina LE; Andreeva IuIu; Shtil' AA; Frank GA
    Arkh Patol; 2008; 70(5):57-61. PubMed ID: 19137788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular testing of human papillomavirus in cervical specimens.
    Gazzaz FB
    Saudi Med J; 2007 Dec; 28(12):1810-8. PubMed ID: 18060207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of efficacy of combined use of liquid cytology and immunohistochemical assay of p16ink4 and standard procedure and high risk evaluation by polymerase chain reaction of human papillomavirus infection in diagnosing cervical dysplasia and carcinoma].
    Raskin GA; Petrov SV; Orlova RV; Mal'tseva LI; Akhmetzianova AV; Farrakhova LN; Khasanov RSh
    Vopr Onkol; 2009; 55(2):192-5. PubMed ID: 19514374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
    Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
    Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.
    Sharpless KE; O'Sullivan DM; Schnatz PF
    J Low Genit Tract Dis; 2009 Apr; 13(2):72-8. PubMed ID: 19387126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.